- Publication
- Jul 20, 2015
Type II kinase inhibitors show an unexpected inhibition mode against Parkinson-s disease-linked LRRK2 mutant G2019S
Liu, et al. Biochemistry, 2013, 52, 1725-1736- Publication
- Jul 20, 2015
Scaffold-based pan-agonist design for the PPAR’, PPAR’ and PPAR’ receptors
Zhang L.S.; Wang S.Q.; Xu W.R.; Wang R.L.; Wang J.F., PLos ONE, 2012, 7(10), DOI: 10.1371/journal.pone.0048453- Publication
- Jul 20, 2015
Design Potential Selective Inhibitors for Treating Cancer by Targeting the Src Homology 2 (SH2) Domain-Containing Phosphatase 2 (Shp2) with Core Hopping Approach
Duan Y.Q.; Ma Y.; Wang X.J.; Jin Y.Y.; Wang R.L.; Dong W.L.; Xu W.R.; Kong D.X.; Wang S.Q., Protein Pept. Lett., 2014, (21)6, 556-563(8)- Publication
- Jul 17, 2015
Structure tuning of pyrazolylpyrrole derivatives as ERK inhibitors utilizing dual tools; 3D-QSAR and side-chain hopping
Kim MH, et al. Bioorg Med Chem Lett, 2011, 21(16), 4900-4- Publication
- Jul 17, 2015
Structure based inhibitor design targeting glycogen phosphorylase B. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-‘-d-glucopyranosylamines
Parmenopoulou V et al., Bioorg Med Chem, 2014, 22(17), 4810-25- Publication
- Jul 17, 2015
Consensus Induced Fit Docking (cIFD): Methodology, validation, and application to the discovery of novel Crm1 inhibitors
Kalid, et al. J. Comput. Aided Mol. Des., 2012, 26, 1217-1228- Publication
- Jul 17, 2015
Improved docking of polypeptides with Glide
Tubert-Brohman, et al. J. Chem. Inf. Model., 2013, 53(7), 1689-1699- Publication
- Jul 17, 2015
Sequence Selectivity of Macrolide-Induced Translational Attenuation
Davis, et al. PNAS, 2014, 111(43), 15379-15384- Publication
- Jul 17, 2015
Boosting virtual screening enrichments with data fusion: Coalescing hits from two-dimensional fingerprints, shape, and docking
Sastry, et al. J. Chem. Inf. Model., 2013, 53, 1531-1542- Publication
- May 1, 2015
Additional disulfide bonds in insulin: Prediction, recombinant expression, receptor binding affinity, and stability
Vinther, et al. Protein Sci, 2015, 24(5), 779-88- Publication
- Feb 15, 2015
Computational Tool for Fast In silico Evaluation of hERG K+ Channel Affinity
Chemi, et al. Front. Chem., 2017, 5 (7), 1-9- Publication
- Feb 15, 2015
Exploring Clotrimazole-based Pharmacophore: 3D-QSAR Studies and Synthesis of Novel Antiplasmodial Agents
Brogi, et al. Bioorganic & Medicinal Chemistry Letters, 2015, 25 (22), 5412-5418
Latest insights from Extrapolations blog
With FEP+, “The Experiment is the Limit.”
Over the past century, small molecule drugs have represented the dominant modality in drug research, enabling medical breakthroughs that have saved countless lives.
Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods
The complexity and size of drug candidates has grown in recent years as scientists pursue novel targets once considered undruggable.
Blog
Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In
We recently sat down with Edward Miller, Senior Director of Protein Structure Modeling at Schrödinger, to discuss his experience using AlphaFold models for SBDD.
Training & Resources
Online certification courses
Level up your skill set with hands-on, online molecular modeling courses. These self-paced courses cover a range of scientific topics and include access to Schrödinger software and support.
Free learning resources
Learn how to deploy the technology and best practices of Schrödinger software for your project success. Find training resources, tutorials, quick start guides, videos, and more.
Other Resources